Catheter Precision (VTAK) Stock Statistics & Valuation Metrics

Catheter Precision has a market cap or net worth of $2.50M. The enterprise value is $11.26M.

Catheter Precision has 9,268,632 shares outstanding. The number of shares has decreased by -2.65% in one year.

Catheter Precision’s return on equity (ROE) is -3.33 and return on invested capital (ROIC) is -273.73%.

The current PE Ratio of Catheter Precision is -0.31. Catheter Precision’s PEG ratio is <0.01.

In the last 12 months, Catheter Precision had revenue of 442.00K and earned -70.57M in profits. Earnings per share was -12.99.

In the last 12 months, operating cash flow was -8.30M and capital expenditures -85.00K, giving a free cash flow of -8.38M billion.

Catheter Precision pays an annual dividend of ―, resulting in a dividend yield of ―

Catheter Precision upcoming earnings date is Nov 13, 2024, TBA Not Confirmed.

Catheter Precision as a current ratio of 1.68, with Debt / Equity ratio of 14.69%

In the past 12 months, Catheter Precision has paid 0.00 in taxes.

Catheter Precision EV to EBITDA ratio is -1.26, with an EV/FCF ratio of -0.92.

Catheter Precision has $1.27M in cash and marketable securities with $63.00K in debt, giving a net cash position of $616.00K billion.

Gross margin is 90.48%, with operating margin of -17673.98%, and net profit margin of -15966.52%.

The average price target for Catheter Precision is ―, which is 11.43% higher than the current price. The consensus rating is ―